why choose us

First received: April 12, 2023

Clinical Trial: A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566

Study Status: Completed

Recruit Status: RECRUITING

Condition: Rheumatoid Arthritis

Study Type: INTERVENTIONAL


Official Title: A Two-part, Randomized Partially-blinded, Parallel-group, Placebo- and Active Comparator-controlled Phase 1 Study to Evaluate the Photosafety of Repeated Oral Dose of SAR441566 in Healthy Adult Partic

Brief Summary: This is a single center randomized parallel-group partially-blinded, 4-arm Phase 1 study to evaluate the phototoxic potential of two dose levels of SAR441566 treatment compared to placebo and the active comparator, ciprofloxacin, in healthy adults, 18 to 55 years of age.There will be two parts:Part I is a randomized placebo-controlled trial comparing sensitivity to ultraviolet (UV) light in participants treated with SAR441566 to those treated with placebo.Part II is an open label arm consisting of participants…

Read more